Medical Cannabis

Israel leads the world in researching and prescribing medical cannabis. Doctors have been legally offering it to patients since 1999 and Israel now imports more cannabis for medical use than any country in the world. But there are still barely 100 doctors who are licensed to prescribe it – out of around 30,000 – and […]

Ra’anana-based Cannbis looks to become go-to information resource and online marketplace for licensed consumers, now numbering over 100,000.

Cannbit-Tikun Olam Pharmaceuticals will produce medical cannabis products for Teva Israel, to be administered as oils rich in THC and CBD.

Growor teamed up with Kolas to develop a sustainable and efficient means to cultivate cannabis using indoor farming.

Syqe Medical is proud to bring this first-in-class device, which delivers a specific dose of cannabinoids with each inhalation.

Doctors at Beilinson Hospital say a majority of patients given cannabidiol (CBD) to calm inflammation were released in under a month.

CanBreed says this is the first time a commercial company has managed to gene-edit cannabis using CRISPR technology.

The 5th International Medical Cannabis Conference covering a variety of topics in the industry, will take place October 26-28.

Cannabis tech company GemmaCert developed products that analyze the potency and composition of cannabis flowers in 5 minutes.

A new study is showing that precise, inhaled doses of THC can effectively relieve pain in patients who are chronic sufferers.

Clinical trials for the potential treatment and prevention of COVID-19 using medical cannabis are scheduled to begin at Rambam Health Care Campus in the next few months.

There are already more than 10 medical cannabis farms and five factories in Israel that meet all the standards and requirements set by the Health Ministry.

CanNegev will be operated by a consortium that includes OurCrowd, BoL Pharma, and Perrigo, with a budget of some $43 million over the course of 5 years.

Israel is wrapping up a 'really tough year,' but any developing market with multi-billion-dollar potential is bound to suffer some growing pains, says Yona Cymerman of Can Innovations.

Spinnaker Opportunities will buy the entire issued share capital of the Israeli medical cannabis R&D firm, according to the deal.